Founded in 1998, OPIS is a global full‑service CRO with 27 years of experience supporting Phase I–IV, medical device, and interventional studies worldwide. With over 1,500 studies delivered and teams across 18 countries, OPIS provides end‑to‑end clinical trial execution driven by scientific expertise and operational excellence.
Northern Bio
Northern Bio is a preclinical CRO that specializes in targeted drug delivery, molecular biology, and bioanalysis to develop safe and effective treatments for devastating diseases. Using advanced surgical techniques and research, we maximize therapeutic impact. Collaboration and open communication are key to the strong partnerships we have with our sponsors. Committed to excellence, Northern Bio transforms possibilities into reality, paving the way for better lives through rigorous research and scientific advancement.
MERIT
MERIT has provided image collection, centralized reading, and data management services for clinical trials since 2012. Through innovative and proven technologies, alongside our intuitive, seamless workflows, MERIT’s experienced staff bring more than a decade of clinical endpoint expertise, ensuring the success and integrity of your clinical trials. Our team has managed 100+ oncology studies across 20+ cancer types. MERIT values your partnership and will make your study a priority! Connect with us by email at oncology@meritcro.com or call (608) 509-7122. | MERIT provides reliable and attentive expertise for your clinical trial endpoint analysis. We specialize in respiratory studies, offering agile centralized spirometry expertise. MERIT has a proven track record providing endpoint expertise to 12 of the top 20 global pharma companies. We conduct studies across the globe, supporting sites in 63 countries. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
Medpace
Medpace is a scientifically-driven, global, full-service CRO providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including nephrology, oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.
MediNect Ophtho
MediNect Ophtho is a specialist preclinical research division of MediNect Bioservices Ltd., focused on accelerating therapeutic development for retinal and ocular diseases. The team combines deep expertise in in vivo, ex vivo, and advanced in vitro models, including diabetic macular edema, retinal degeneration, and subretinal fibrosis. With a strong scientific foundation—over 80% of staff holding PhDs—and leadership experienced in advancing drugs to clinical trials, MediNect Ophtho delivers high-quality, translational data to support decision-making from early discovery through to IND-enabling studies. By integrating academic insight with CRO delivery, the group provides flexible, bespoke study design tailored to biotech and pharmaceutical partners worldwide.
M&S Technologies
M&S Technologies is excited to showcase the latest innovations in vision care solutions! M&S Clinical Trial Suite, CTS consists of a variety of visual acuity and contrast sensitivity protocols that easily step the user through the eye charts presented and directly respond to user input regarding correct/incorrect results. M&S Technologies introduces the DVA-5000 for Clinical Trial ETDRS and Contrast Sensitivity Function testing. Experience the Smart System® VR Headset for reliable visual field testing, and explore the NEW Smart System 3 | 2020, now featuring patient education media. Plus, see the advanced M&S | Bruder Ocular Surface Analyzer in action. Visit us at Booth #8038